Sort   by:  
 Page size 
UnknownTumor Mutational Burden as a Predictor of Survival with Durvalumab and/or Tremelimumab Treatment in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.
Not available
S-EPMC10233352 | biostudies-literature
UnknownEffect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical Trial.
Not available
S-EPMC5313044 | biostudies-literature
UnknownClinical and cost effectiveness of booklet based vestibular rehabilitation for chronic dizziness in primary care: single blind, parallel group, pragmatic, randomised controlled trial.
Not available
S-EPMC3368486 | biostudies-literature
UnknownDiscovery of a Potent and Selective Targeted NSD2 Degrader for the Reduction of H3K36me2.
Not available
S-EPMC10116495 | biostudies-literature
UnknownBRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance.
Not available
S-EPMC10055590 | biostudies-literature
UnknownSecondary Somatic Mutations Restoring <i>RAD51C</i> and <i>RAD51D</i> Associated with Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma.
Not available
S-EPMC5612362 | biostudies-literature
UnknownRISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response.
Not available
S-EPMC7248089 | biostudies-literature
UnknownBRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance.
Not available
S-EPMC11299415 | biostudies-literature
UnknownBreast cancer management pathways during the COVID-19 pandemic: outcomes from the UK 'Alert Level 4' phase of the B-MaP-C study.
Not available
S-EPMC7993073 | biostudies-literature
UnknownGenome-wide association study in frontal fibrosing alopecia identifies four susceptibility loci including HLA-B*07:02.
Not available
S-EPMC6408457 | biostudies-literature
Sort   by:  
 Page size